abstract: Risk of Malignancy in Sonographically Confirmed Ovarian Tumors

Abstract

Ovarian cancer is the leading cause of gynecologic cancer death in the United States. Once an ovarian tumor is identified, a pelvic ultrasound is recommended, including tumor volume and tumor structure. Unilocular and simple septate tumors are unlikely to be malignant and when asymptomatic, can be safely followed conservatively without surgery. Complex ovarian tumors are at an increased risk for malignancy and secondary testing is recommended. Secondary testing may include CA125, OVA1, the RMI, ROMA, or the ACOG referral guidelines. When secondary testing indicates that an ovarian tumor is at high risk for malignancy, referral to a gynecologic oncologist is recommended.

abstract: A survey of gynecologic oncologists regarding the End-of-Life discussion: A pilot study

Results.

Response rate was 12.8%.

 Highlights

► A survey was sent to 1105 gynecologic oncologists to evaluate practices and attitudes regarding the end-of-life discussion
► This discussion appears to be had late
► This may contribute to patients' inability to effectively take part in her plan of care

Search Results: gynae/gynecologic oncologist - 2011 ASCO Abstracts

No documents found relating to your query/s.

---

Find EXACT phrase: gynecologic oncologist
 Find EXACT phrase: gynaecologic oncologist

Anatomy for the Gynecologic Oncologist PDF ebook online

Anatomy for the Gynecologic Oncologist PDF ebook online

(references SGO presentation) PCPs less likely to refer patients to gynecologic oncologists | HemOncToday

"..........Just 39.3% of family physicians and 51% of internists reported that they would refer the patient to the gynecologic oncologist. They were much more likely to refer their patients to obstetrician-gynecologists. Among obstetrician-gynecologists, however, two-thirds reported that they would refer a patient with abdominal pain and a suspicious ovarian mass to a gynecologic oncologist.........One-third of the obstetrician-gynecologists reported that they would operate on the patient themselves.........."

Goff B. #10. Presented at: the 42nd Annual Meeting of the Society of Gynecologic Oncologists; March 6-9, 2011, Orlando, Fla.

Ovarian cancer care for the underserved: Are surgical patterns of care different in a public hospital setting? abstract

CONCLUSIONS:

Ovarian cancer patients treated in public hospitals are less likely to have gynecologic oncologists and high-volume surgeons involved in their care. This is a preliminary finding that warrants further investigation.

Regina left without a gynecologic oncologist

Regina Specialist (Gynecologic Oncologist) On the Move, Media Release

How Does Older Age Influence Oncologists' Cancer Management?

Conclusions. 
Advanced age can deter oncologists from choosing intensive cancer therapy, even if patients are highly functional and lack comorbidities. Education on tailoring cancer treatment and a greater use of comprehensive geriatric assessment may reduce cancer undertreatment in the geriatric population.

(U.S.) Society of Gynecologic Oncologists Releases Data on the State of the Specialty

"SGO Practice Survey Task Force Chairman James Orr, MD, said in a news release, “The information in this report is a useful tool not only to current, practicing gynecologic oncologists with regard to how their practice composition relates to their peers, but also has important implications for individuals considering a career in this subspecialty, medical schools interested in creating a specialty program, and hospitals and health systems investigating the addition of specialized cancer care to their women's health care programs.”"

Subject: Q&A with Hannah Ortiz, gynecologic oncologist in Long Island, New York (media interview)

"Is there a shortage of gynecologists on the North Fork?

I am the only gynecologist who has an office [full time] on the North Fork. And I'm the only gynecologist who has had a permanent office on the North Fork in 25 years. I'm not talking specialty. I'm talking general gyn. Riverhead is the town where the North and South forks separate. There are two ob-gyn practices in Riverhead. And there are several on the South Fork of Long Island, East Hampton, Southampton and Hampton Bays. The only [full-time] gyn practice on the North Fork driving east is mine."

ASCO: Continuity of care for cancer patients at the end of life (EoL). -- Bascioni et al. 28 (15): 6145 -- ASCO Meeting Abstracts

Conclusion: Continuity of care at the EoL is a priority issue for the families of cancer pts. The daily routine of palliative care and hospice facilities should involve the oncologist to improve the experience of care. Patients' families expect a commitment by the oncologist in bereavement activities.

amednews: Gynecologic oncologists moving away from private practice

It's a choice to move forward: women's perceptions about treatment decision making in recurrent ovarian cancer

Abstract
OBJECTIVE: This research explores the treatment decision-making (TDM) experiences of women with recurrent ovarian cancer (ROC) with regard to treatment options; their understanding of risks and benefits of various treatment options; the decision-making role they want for themselves and for their oncologist; and the social context of the consultation as it pertains to the decision.
METHODS: We conducted semi-structured interviews with 26 women at the time of first recurrence. Through inductive data analysis key themes were identified.
RESULTS: Many women describe self-identifying the cancer recurrence fairly quickly due to new symptoms. Many feel that the goal for treating their recurrence is to control versus cure the cancer. They describe the subsequent process of diagnosis and TDM for ROC as quick and straightforward with all women accepting the oncologists' treatment recommendation. They feel that the type and number of treatment options are limited. They have a strong desire for physician continuity in their care. Participants feel that their doctor's recommendations as well as their previous experience with ovarian cancer are strong factors influencing their current TDM process.
CONCLUSIONS: Shared decision making is based on a simultaneous participation of both the physician and patient in TDM. When faced with ROC, women feel that their doctor's recommendation and their past experience with treatment and TDM are prominent factors influencing the current TDM process.

Letter to the Edfitor: Leader Post April 14th Loss of gynecologic specialist putting women's lives at risk

"No one will own the problem" Departing oncologist cites frustration - Dr. Lizabeth Brydon Saskatchewan

"No one will own the problem and it is a problem," Brydon said. "The fact of my leaving puts more pressure on it. I realize by doing this I have created a crisis, but we've given them two drop-dead dates saying, 'We're closing our office here because we can't cope.' "